Published in Mol Vis on March 27, 2008
Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One (2009) 2.00
IL-2 and IFN-gamma in the retina of diabetic rats. Graefes Arch Clin Exp Ophthalmol (2010) 1.56
Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion. Jpn J Ophthalmol (2011) 1.41
Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes. Cytokine (2012) 1.38
Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease. Am J Pathol (2009) 1.37
Diabetic retinopathy and inflammation: novel therapeutic targets. Middle East Afr J Ophthalmol (2012) 1.35
Inflammation and diabetic retinal microvascular complications. J Cardiovasc Dis Res (2011) 1.33
Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness. Mol Vis (2009) 1.19
Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy. Diabetes (2010) 1.05
Dexamethasone intravitreal implant in the treatment of diabetic macular edema. Clin Ophthalmol (2015) 1.05
Role of inflammation in the pathogenesis of diabetic retinopathy. Middle East Afr J Ophthalmol (2012) 1.04
Inflammation and pharmacological treatment in diabetic retinopathy. Mediators Inflamm (2013) 1.00
Anti-inflammatory therapy for diabetic retinopathy. Immunotherapy (2011) 0.98
Changes to tear cytokines of type 2 diabetic patients with or without retinopathy. Mol Vis (2010) 0.90
Expression of T-helper-associated cytokines in patients with type 2 diabetes mellitus with retinopathy. Mol Vis (2012) 0.90
Impact of interleukin-6 promoter polymorphism and serum interleukin-6 level on the acute inflammation and neovascularization stages of patients with Eales' disease. Mol Vis (2011) 0.88
Comparison of aqueous concentrations of angiogenic and inflammatory cytokines based on optical coherence tomography patterns of diabetic macular edema. Indian J Ophthalmol (2015) 0.86
Multiplex bead array assay of plasma cytokines in type 2 diabetes mellitus with diabetic retinopathy. Mol Vis (2014) 0.83
Endoplasmic reticulum stress-regulated CXCR3 pathway mediates inflammation and neuronal injury in acute glaucoma. Cell Death Dis (2015) 0.81
Intravitreous high expression level of netrin-1 in patients with proliferative diabetic retinopathy. Eye Sci (2011) 0.80
Interrelationship Between Periapical Lesion and Systemic Metabolic Disorders. Curr Pharm Des (2016) 0.79
Early post-operative measurement of cytokine plasma levels combined with pre-operative bilirubin levels identify high-risk patients after liver resection. Int J Mol Med (2010) 0.79
Vitreous mediators in retinal hypoxic diseases. Mediators Inflamm (2013) 0.79
Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes. Invest Ophthalmol Vis Sci (2013) 0.78
Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes? Cardiovasc Diabetol (2016) 0.78
Constitutive and LPS-induced expression of MCP-1 and IL-8 by human uveal melanocytes in vitro and relevant signal pathways. Invest Ophthalmol Vis Sci (2014) 0.76
The Measurement of Intraocular Biomarkers in Various Stages of Proliferative Diabetic Retinopathy Using Multiplex xMAP Technology. J Ophthalmol (2015) 0.75
Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic ß-cells for effective management of type 1 diabetes mellitus. Br J Pharmacol (2017) 0.75
Safety and Feasibility of Quantitative Multiplexed Cytokine Analysis From Office-Based Vitreous Aspiration. Invest Ophthalmol Vis Sci (2016) 0.75
Aqueous humor pentraxin-3 levels in patients with diabetes mellitus. Eye (Lond) (2017) 0.75
Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications. Sci Rep (2017) 0.75
Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med (1996) 6.36
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood (2000) 4.34
Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol (2003) 3.70
Diabetic retinopathy. Diabetes Care (1998) 3.39
Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes (1997) 3.08
Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis. Proc Natl Acad Sci U S A (2007) 2.20
Loss of vision before ophthalmic referral in blind and partially sighted diabetics in Bristol. Br J Ophthalmol (1994) 2.08
Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol (1994) 2.00
Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood (2004) 1.99
Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci (2005) 1.92
Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer (2003) 1.80
Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes (1999) 1.76
Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1 beta. J Exp Med (1988) 1.68
Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. Invest Ophthalmol Vis Sci (2005) 1.61
Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Eur Cytokine Netw (2006) 1.52
Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders. Invest Ophthalmol Vis Sci (2007) 1.38
Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy. Diabet Med (2005) 1.36
Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells. J Cell Sci (2003) 1.32
Regulation and function of the CXC chemokine ENA-78 in monocytes and its role in disease. J Leukoc Biol (1997) 1.31
Elevated serum IP-10 levels observed in type 1 diabetes. Diabetes Care (2001) 1.28
Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002. Diabetologia (2006) 1.28
Chemokine-leukocyte interactions. The voodoo that they do so well. Cytokine Growth Factor Rev (1996) 1.24
Vascular endothelial growth factor-induced signaling pathways in endothelial cells that mediate overexpression of the chemokine IFN-gamma-inducible protein of 10 kDa in vitro and in vivo. J Immunol (2006) 1.24
Altered chemokine levels in individuals at risk of Type 1 diabetes mellitus. Diabet Med (2006) 1.23
Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy. Ophthalmologica (2001) 1.23
Upregulation of chemokine expression in the retinal vasculature in ischemia-reperfusion injury. Invest Ophthalmol Vis Sci (2003) 1.22
Determination of cytokine responses using a multiplexed fluorescent microsphere immunoassay. Am J Clin Pathol (2002) 1.19
Role of MCP-1 and MIP-1alpha in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization. J Leukoc Biol (2003) 1.16
C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy. Retina (1998) 1.15
Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro. J Surg Res (1993) 1.14
Induction of IL-8, MCP-1, and bFGF by TNF-alpha in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation. Graefes Arch Clin Exp Ophthalmol (2004) 1.13
Chemokines and incident coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Arterioscler Thromb Vasc Biol (2006) 1.04
Interferon-induced protein 10 and interleukin 8. C-X-C chemokines present in proliferative diabetic retinopathy. Arch Ophthalmol (1998) 1.01
Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy. Ophthalmic Res (2005) 0.98
Cytokine regulation of RANTES production by human retinal pigment epithelial cells. Cell Immunol (1998) 0.97
Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy. Ophthalmic Res (2007) 0.96
Application of multiplex cytometric bead array technology for the measurement of angiogenic factors in the vitreous. Mol Vis (2006) 0.94
Induction of macrophage inflammatory protein-1alpha and vascular endothelial growth factor during inflammatory neovascularization in the mouse cornea. Angiogenesis (1999) 0.94
Alteration pattern of tear cytokines during the course of a day: diurnal rhythm analyzed by multicytokine assay. Cytokine (2006) 0.94
Inflammatory mediators are perpetuated in macrophages resistant to apoptosis induced by hypoxia. Proc Natl Acad Sci U S A (1997) 0.93
Electron microscopic evidence for the mechanism of blood-retinal barrier breakdown in diabetic rabbits: comparison with magnetic resonance imaging. Pathol Res Pract (1998) 0.86
Chlamydia pneumoniae seropositivity and the risk of nonarteritic ischemic optic neuropathy. Ophthalmology (2002) 2.77
A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration. Br J Ophthalmol (2013) 2.31
Fibulin-5 mutations link inherited neuropathies, age-related macular degeneration and hyperelastic skin. Brain (2011) 2.15
Incidence of rhegmatogenous retinal detachment after vitrectomy in eyes of diabetic patients. Retina (2006) 1.58
Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion. Ophthalmology (2002) 1.48
Lysyl oxidase-like protein 1 (LOXL1) gene polymorphisms and exfoliation glaucoma in a Central European population. Mol Vis (2008) 1.43
Evolution of early changes at the vitreoretinal interface after cataract surgery determined by optical coherence tomography and ultrasonography. Am J Ophthalmol (2012) 1.43
Mitochondrial DNA haplogroup T is associated with coronary artery disease and diabetic retinopathy: a case control study. BMC Med Genet (2009) 1.27
Endurance exercise training in orthostatic intolerance: a randomized, controlled trial. Hypertension (2005) 1.25
DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med (2003) 1.22
Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration. Ophthalmology (2007) 1.13
Twenty-three-gauge and 20-gauge vitrectomy in epiretinal membrane surgery. Retina (2010) 1.11
Evaluation of the clinical course of dry eye syndrome. Arch Ophthalmol (2003) 1.11
Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure. Crit Care (2006) 1.10
The effect of a single infusion of zoledronic acid on early implant migration in total hip arthroplasty. A randomized, double-blind, controlled trial. J Bone Joint Surg Am (2009) 1.08
Intrusion of an encircling buckle after retinal detachment surgery. Am J Ophthalmol (2003) 1.02
Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol (2002) 1.01
Comparing polymethylmethacrylate implant with collagen implant in deep sclerectomy: a randomized controlled trial. J Glaucoma (2006) 1.00
Long-term effect of phacoemulsification on intraocular pressure after trabeculectomy. J Cataract Refract Surg (2002) 1.00
Association of the HTRA1 -625G>A promoter gene polymorphism with exudative age-related macular degeneration in a Central European population. Mol Vis (2007) 0.99
Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study. Acta Ophthalmol Scand (2005) 0.99
Evaluation of polymerase chain reaction for the detection of adenoviruses in conjunctival swab specimens using degenerate primers in comparison with direct immunofluorescence. Ophthalmologica (2002) 0.98
The role of the carotenoids, lutein and zeaxanthin, in protecting against age-related macular degeneration: a review based on controversial evidence. Nutr J (2003) 0.97
Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium. Clin Chem Lab Med (2003) 0.96
The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion. Am J Ophthalmol (2002) 0.94
Application of multiplex cytometric bead array technology for the measurement of angiogenic factors in the vitreous. Mol Vis (2006) 0.94
Use of true net power in intraocular lens power calculations in eyes with prior myopic laser refractive surgery. Int Ophthalmol (2014) 0.94
TNF-alpha -308 G>A and -238 G>A polymorphisms are not major risk factors in Caucasian patients with exfoliation glaucoma. Mol Vis (2009) 0.93
Long-term follow-up of punctal and proximal canalicular stenoses after silicone punctal plug treatment in dry eye patients. Am J Ophthalmol (2008) 0.93
Intravitreal methotrexate in the management of presumed tuberculous serpiginous-like choroiditis. Retina (2013) 0.92
Role of thrombophilic gene polymorphisms in branch retinal vein occlusion. Ophthalmology (2005) 0.90
Methylenetetrahydrofolatereductase (MTHFR) 677C>T polymorphism and open angle glaucoma. Mol Vis (2006) 0.89
The effect of intravitreal triamcinolone on diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol (2004) 0.89
Role of functional single nucleotide polymorphisms of MMP1, MMP2, and MMP9 in open angle glaucomas. Mol Vis (2010) 0.89
Role of vascular endothelial growth factor polymorphisms in the treatment success in patients with wet age-related macular degeneration. Ophthalmology (2012) 0.89
Twenty years of acanthamoeba diagnostics in Austria. J Eukaryot Microbiol (2014) 0.88
Incidence of radiation retinopathy after high-dosage single-fraction gamma knife radiosurgery for choroidal melanoma. Ophthalmology (2002) 0.87
Role of cholesterol 24S-hydroxylase gene polymorphism (rs754203) in primary open angle glaucoma. Mol Vis (2011) 0.87
Blood polymorphonuclear leukocyte migration as a predictive marker for infections in severe trauma: comparison with various inflammation parameters. Intensive Care Med (2004) 0.87
No cognitive deficits in men formerly exposed to lead. Wien Klin Wochenschr (2005) 0.86
Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol (2002) 0.86
IL2RA gene polymorphism rs2104286 A>G seen in multiple sclerosis is associated with intermediate uveitis: possible parallel pathways? Invest Ophthalmol Vis Sci (2011) 0.86
Role of the CCL2/MCP-1 -2518A>G gene polymorphism in HLA-B27 associated uveitis. Mol Vis (2005) 0.86
Surgical smoke management for minimally invasive (micro)endoscopy: an experimental study. Surg Endosc (2010) 0.86
Long-term follow-up with I-CARE phakic IOLs. Br J Ophthalmol (2010) 0.85
Acute effects of electromagnetic fields emitted by GSM mobile phones on subjective well-being and physiological reactions: a meta-analysis. Sci Total Environ (2012) 0.85
Biometry and refractive outcome of eyes filled with silicone oil by standardized echography and partial coherence interferometry. Graefes Arch Clin Exp Ophthalmol (2005) 0.85
Leopard-spot pattern of yellowish subretinal deposits in central serous chorioretinopathy. Arch Ophthalmol (2002) 0.84
The angiotensin-converting enzyme insertion/deletion and the endothelin -134 3A/4A gene polymorphisms in patients with chronic plaque psoriasis. Exp Dermatol (2007) 0.84
Ozurdex(®) reduces the retinal thickness in radiation maculopathy refractory to bevacizumab. Acta Ophthalmol (2014) 0.84
Coinfection of the retina by Epstein-Barr virus and cytomegalovirus in an AIDS patient. Am J Ophthalmol (2002) 0.84
The methylenetetrahydrofolate reductase 677C>T gene polymorphism is not associated with chronic plaque psoriasis. Exp Dermatol (2008) 0.83
Ocular trauma scores in paediatric open globe injuries. Br J Ophthalmol (2014) 0.83
Role of the interleukin 15 96516A>T and IL15 96330C>A gene polymorphisms in Caucasian patients with chronic plaque psoriasis. J Dermatol Sci (2008) 0.83
Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations. Ophthalmology (2006) 0.82
Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration. Am J Ophthalmol (2006) 0.82
Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion. Acta Ophthalmol Scand (2005) 0.82
Impairment of homocysteine metabolism in patients with retinal vascular occlusion and non-arteritic ischemic optic neuropathy. Clin Chem Lab Med (2005) 0.82
Chlamydial conjunctivitis (in adults), uveitis, and reactive arthritis, including SARA. Sexually acquired reactive arthritis. Best Pract Res Clin Obstet Gynaecol (2002) 0.82
Foreign-body reaction after reconstruction of complete acromioclavicular dislocation using PDS augmentation. J Shoulder Elbow Surg (2004) 0.82
Pupil ovalization after phakic intraocular lens implantation is associated with sectorial iris hypoperfusion. Arch Ophthalmol (2005) 0.82
Risk assessment of idiopathic macular holes undergoing vitrectomy with dye-assisted internal limiting membrane peeling. Retina (2013) 0.82
Evaluation of ocular surface and tear film function following modified Hughes tarsoconjunctival flap procedure. Acta Ophthalmol (2013) 0.82
Combination treatment of photodynamic therapy with verteporfin and intravitreal ranibizumab in patients with retinal angiomatous proliferation. Acta Ophthalmol (2013) 0.81
Association of preoperative optical coherence tomography markers with residual inner limiting membrane in epiretinal membrane peeling. PLoS One (2013) 0.81
Role of the interleukin-6 -174 G>C gene polymorphism in retinal artery occlusion. Stroke (2004) 0.81
Prevalence of early and late stages of physiologic PVD in emmetropic elderly population. Acta Ophthalmol (2011) 0.81
Angiotensin-converting enzyme insertion/deletion polymorphism and retinal artery occlusion. Acta Ophthalmol Scand (2006) 0.81